US Patent Issued to THAUMACHRON on April 14 for "De novo generation of high diversity proteins in silico with selective affinity and cross-reactivity minimization" (South Dakota Inventor)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,603,153, issued on April 14, was assigned to THAUMACHRON LLC (Rapid City, S.D.).

"De novo generation of high diversity proteins in silico with selective affinity and cross-reactivity minimization" was invented by Andrew Simpson (Summerset, S.D.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure relates to a platform for de novo in silico generation of high diversity protein complexes, namely antibodies and TCRs, with selective affinity and cross-reactivity minimization given the antigen complex's sequences and additional conditional information."

The patent was filed on Aug. 6, 2021, under Application No. 17/396,197.

*For further informat...